We're dipping into our large cash pile to buy this bank on Thursday's sell-off

Jim Cramer's Charitable Trust is buying 10 Goldman Sachs shares at roughly $867, raising its holding to 160 shares and portfolio weighting to 3.6% from 3.4%. Goldman is down roughly 7% amid concerns that opposition to data centers could reduce AI-related IPOs and fundraising; Cramer says the stock may face further downside but points to its trading businesses, 2.3% dividend yield and quarterly multibillion-dollar buybacks. Investment banking is expected to represent about 36% of 2027 sales, according to FactSet.

Analysis

The key exposure is not simply AI enthusiasm: it is whether data-center opposition delays financing activity enough to weaken Goldman’s underwriting pipeline, versus whether volatility lifts trading revenue and offsets that pressure. Those channels have different timing—trading can respond within a quarter, while IPO and financing effects may take several quarters to show in realized fees. The offset is not automatic: persistent risk-off conditions can reduce client activity as well as deal volumes, and capital returns do not prevent multiple compression if earnings expectations fall.

The small trust purchase is weak evidence of institutional conviction and should not be treated as a catalyst. The more useful signal is whether the market is pricing a temporary deal slowdown or a broader deterioration in capital markets. Compare Goldman’s subsequent advisory and underwriting trends with trading results and guidance; competitor commentary from Morgan Stanley and other large banks can help distinguish company-specific execution from sector conditions.

For Boeing, the article supplies no new operating evidence beyond management’s cash-flow reset. Its weakness is not an AI read-through; treat any addition as a separate manufacturing, delivery, and cash-conversion thesis. Near term, both stocks remain exposed to broad risk appetite. Over 6–18 months, the GS thesis depends on durable fee generation and capital returns, not a rebound in AI headlines alone.

Key Decisions for Investors

• GS: Avoid chasing the reported nibble. Consider staged long exposure only if further weakness is not accompanied by cuts to fee-income expectations; reassess against underwriting activity, trading performance, and management guidance over the next 1–3 months.
• Use Morgan Stanley or a broad financials benchmark as a relative-performance check rather than assuming GS is insulated by trading. The thesis is impaired if GS underperforms peers while deal activity and trading revenues both weaken, or if capital returns are reduced.
• BA: Keep separate from the AI/data-center trade. Do not add solely because of a market sell-off; require evidence that the cash-flow reset is achievable, especially in free cash flow, deliveries, and production execution.
• Treat sustained resistance to data-center development as a downside catalyst for AI-linked financing demand, but verify project delays and bank guidance before extrapolating it into a durable decline in Goldman’s fees.